Monthly Communication Report

Organization:	Novo Nordisk Canada Inc.
Associated registration:	954988-360616-20
Communication date:	2025-07-23
Posted date:	2025-08-15

Designated Public Office Holders who participated in the communication:	Shahad Khallidi, Deputy Director of Policy Office of the Minister of Health, Health Canada (HC) Sandenga Yeba, Director of Policy Minister's Office, Health Canada (HC)
List of Details Subject matter Detail Health, International Trade Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.
Responsible Officer who filed this communication report:	Vince Lamanna
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.